Orange Book product · Brand (NDA)

LUMIGAN

BIMATOPROST

Brand (NDA)NDA 022184TE ABRX ABBVIE

Aug 31, 2010

Approved

Brand (NDA)

Application

TE code

Listed patents

Approval
FDA approval date of this drug product.
Aug 31, 2010
16 yr ago
Today
Patent 7851504 expires
Listed drug substance patent expiration.
Jun 13, 2027
in 1 yr

Active ingredient

BIMATOPROST

Strength

0.01%

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

TE code

Application

NDA 022184

Product number

001

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
7851504	Jun 13, 2027	in 1 yr	SubstanceProduct